ProfTom Fahey

Professor Tom Fahey is accredited in both Public Health Medicine and General Practice and has an international track record in primary care research. Prior to joining RCSI in 2006 he was Professor of Primary Care Medicine, University of Dundee (2002-6) and Senior Lecturer/Lecturer, University of Bristol (1995-2002). He completed his Public Health Medicine training in Oxford (1992-5).

He led Ireland's national programme for primary care research- the HRB Centre for Primary Care Research (www.hrbcentreprimarycare.ie) between 2008 to 2021. Professor Fahey was awarded the RCGP research paper of the year twice in 2000 and 2003; the John Fry Medal in 2003 (RCGP distinguished research award); was an NHS R&D career scientist (1999-2002); and was named as a British Medical Association Clinical Academic Role Model in 2005. He gave the RCGP James MacKenzie Lecture in 2019.

Professor Fahey is currently a member of the Editorial Board of BMJ Open. Formerly he has been a member of the Editorial Board of the British Medical Journal, the British Journal of General Practice, Evidence-Based Medicine, Family Practice, BMC Family Practice and Medical Decision Making. He has been a member of the Cochrane Acute Respiratory Infections (ARI) Group for 20 years and was comments and criticisms editor for five years. He has provided peer-review comments for over 80 medical journals including Annals of Internal Medicine, the BMJ, JAMA and the Lancet. He is external examiner for the MSc in Evidence-Based Healthcare at the University of Oxford.

He has sat on International funding Panels for Germany (BMBF), the UK (NIHR), Portugal (FCT), Flanders (FWO) and Norway (Norges forskningsråd). He was Chair of the International Assessment Panel for the NIHR School of Primary Care Research and currently Chairs the FWO Med 8 Panel and is a member for FCT (Portugal) Health and Sport sciences panel. He has provided peer review comments for over 40 funding agencies in Belgium, Germany, the Netherlands, Portugal, Switzerland and the UK.

In terms of research governance he has been Chair of NIHR Programme Grants or Trial Steering Committees lead by investigators from the Universities of Bristol, Cardiff, Keele, Nottingham, and Oxford.

He was a Board member of the Health Research Board (HRB) of Ireland 2018-2024 and was a member of the Advisory Committee Human Medicines for the Health Products Regulatory Authority (HPRA) 2014-2020.